Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02257619
Title Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Hot Springs Arizona United States Details
Los Angeles California United States Details
Washington District of Columbia United States Details
Orlando Florida United States Details
Detroit Michigan United States Details
Pascagoula Mississippi United States Details
Kansas City Missouri United States Details
Omaha Nebraska United States Details
Lebanon New Hampshire United States Details
Goldsboro North Carolina United States Details
Cleveland Ohio United States Details
Gettysburg Pennsylvania United States Details
Hershey Pennsylvania United States Details
Pawtucket Rhode Island United States Details
Spartanburg South Carolina United States Details
Round Rock Texas United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field